Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2020 16:05 ET | Source: RAPT Therapeutics, Inc.

Peter Svennilson Elected to RAPT Therapeutics Board of Directors

SOUTH SAN FRANCISCO, Calif., June 18, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...
June 17, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...
May 29, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program

SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
May 26, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...
May 15, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Highlights Early Results for RPT193 at Society for Investigative Dermatology Meeting

SOUTH SAN FRANCISCO, Calif., May 15, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
May 14, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Reports First Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
May 12, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the UBS Virtual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...
March 30, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,...
March 04, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Announces Management Promotions

SOUTH SAN FRANCISCO, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...
February 19, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Announces Upcoming Investor Conference Presentations

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing...